Circular RNA cMTO1 Promotes PTEN Expression Through Sponging miR-181b-5p in Liver Fibrosis

Hui Jin1, Chunxue Li2, Peihong Dong3

  • 1Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Abstract

Insights

Circular RNA cMTO1 inhibits hepatic stellate cell activation and may be a therapeutic target for liver fibrosis. It functions by regulating microRNA-181b-5p and PTEN expression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Hepatology

Background:

  • Circular RNAs (circRNAs) are key regulators in cancer biology.
  • cMTO1 (hsa_circ_0007874) acts as a tumor suppressor in hepatocellular carcinoma (HCC).
  • The role of cMTO1 in liver fibrosis remains largely unexplored.

Purpose of the Study:

  • To investigate the expression and function of cMTO1 in liver fibrosis.
  • To elucidate the molecular mechanism underlying cMTO1's role in hepatic stellate cell (HSC) activation.
  • To assess cMTO1 as a potential therapeutic target for liver fibrosis.

Main Methods:

  • In vivo and in vitro studies of cMTO1 expression and function during liver fibrosis.
  • Luciferase activity and pull-down assays to analyze the interaction between cMTO1 and microRNA-181b-5p (miR-181b-5p).
  • Immunofluorescence analysis to assess the impact of cMTO1 on fibrotic markers (α-SMA, type I collagen).

Main Results:

  • cMTO1 expression was reduced in cirrhotic livers, fibrotic mouse livers, and activated HSCs.
  • Restoring cMTO1 inhibited HSC proliferation and suppressed α-SMA and type I collagen expression.
  • cMTO1 interacts with miR-181b-5p, which targets PTEN, and this interaction mediates cMTO1's inhibitory effect on HSC activation.

Conclusions:

  • cMTO1 inhibits HSC activation, partly via miR-181b-5p-mediated PTEN expression.
  • cMTO1 demonstrates potential as a novel therapeutic target for liver fibrosis.
  • Further research into cMTO1's regulatory network in liver fibrosis is warranted.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.4K